Gladius Capital Management LP Amphastar Pharmaceuticals, Inc. Transaction History
Gladius Capital Management LP
- $174 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
280Shares Held
36.7MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$198 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$90.5 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$71.3 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$65 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$53.9 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.64B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...